Gut Microbiome & Neurodegeneration

Patients with neurodegenerative diseases often have an altered composition of the gut microbiome. Novel reports suggest that there is an extensive crosstalk between the gut microbiome and the brain, and this may influence neurodegeneration. Discover the latest research on how the gut microbiome influences neurodegeneration here.

December 6, 2021
Review
Open Access

Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain.

Frontiers in Immunology
Katiane RoversiSébastien Talbot
December 6, 2021
Review
Open Access

Dietary Regulation of Gut-Brain Axis in Alzheimer's Disease: Importance of Microbiota Metabolites.

Frontiers in Neuroscience
Dulce M FraustoRobin M Voigt
December 3, 2021
Review

Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease.

Curēus
Rahul JenaMichael Alfonso
November 29, 2021
Review

The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Xiangqian LiuSulie L Chang
November 29, 2021
Review

[Advances in fecal microbiota transplantation for treatment of Parkinson's disease].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Minna ZhangXiaozhong Yang
November 29, 2021
Review

[Microbe-gut-brain axis and neurological disorders: a review].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Xin Shen, Zhihong Sun
November 28, 2021
Review
Open Access

Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease.

Microorganisms
Peilin SunChuan Qin
November 25, 2021
Review
Open Access

TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.

Translational Neurodegeneration
Anastazja M GoreckiRyan S Anderton
November 24, 2021
Preprint
Open Access

Probing Gut-Brain Links in Alzheimer's Disease with Rifaximin

MedRxiv : the Preprint Server for Health Sciences
Paul V SuhockiP. M. Doraiswamy
November 23, 2021
Preprint
Open Access

Fecal microbiota transplantation derived from Alzheimer's disease mice worsens brain trauma outcomes in young C57BL/6 mice

BioRxiv : the Preprint Server for Biology
S. SorianoSonia Villapol
November 23, 2021
Review

Neuropathy in COVID-19 associated with dysbiosis-related inflammation.

Turkish Journal of Biology = Türk Biyoloji Dergisi
Busra Aktas, Belma Aslim
November 23, 2021
Open Access

Altered Gut Microbial Load and Immune Activation in a Drosophila Model of Human Tauopathy.

Frontiers in Neuroscience
Jerrik RydbomKelly M Lohr
November 20, 2021
Open Access

Association between Parkinson's disease and the faecal eukaryotic microbiota.

NPJ Parkinson's Disease
Severin WeisMarkus Egert
November 20, 2021
Review

Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology.

International Journal of Nanomedicine
Kshitis Chandra BaralHyo-Kyung Han

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/gut-microbiome-neurodegeneration/47ba9e17-13dd-49c8-a30e-a7c8c7d60b66